Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Im, Jin S
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Akin S
,
Hosing C
,
Khouri IF
,
Ahmed S
,
Alousi A
,
Fowler NH
,
Joseph J
,
Truxillo J
,
Ramdial J
,
Maadani F
, et al.
Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement.
Blood Adv. 2022.
PubMed
Google Scholar
C
Al-Juhaishi T
,
Wang Y
,
Milton DR
,
Xu-Monette ZY
,
Jabbour E
,
Daher M
,
Im JS
,
Bashir Q
,
Iyer SP
,
Marin D
, et al.
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Bone Marrow Transplant. 2023.
PubMed
Google Scholar
M
Popat UR
,
Pasvolsky O
,
Bassett R
,
Mehta RS
,
Olson AL
,
Chen J
,
Alousi AMajid
,
Al-Atrash G
,
Bashir Q
,
Gulbis AM
, et al.
Myeloablative Fractionated Busulfan for Allogeneic Stem Cell Transplant in Older Patients or Patients with Comorbidities.
Blood Adv. 2023.
PubMed
Google Scholar
Mehta RS
,
Bassett R
,
Chen J
,
Valdez BC
,
Kawedia J
,
Alousi AM
,
Anderlini P
,
Al-Atrash G
,
Bashir Q
,
Ciurea SO
, et al.
Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
S
Khouri IF
,
Alzahrani K
,
Kantarjian H
,
Milton DR
,
Gulbis AM
,
Sasaki K
,
Jain N
,
Short NJ
,
Kadia T
,
Daher M
, et al.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol. 2024.
PubMed
Google Scholar
T
Olson A
,
Lin R
,
Marin D
,
Rafei H
,
Bdaiwi MH
,
Thall PF
,
Basar R
,
Abudayyeh A
,
Banerjee P
,
Aung FM
, et al.
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
J Clin Oncol. 2021:JCO2002608.
PubMed
Google Scholar